Unknown

Dataset Information

0

Microglia TREM2: A Potential Role in the Mechanism of Action of Electroacupuncture in an Alzheimer's Disease Animal Model.


ABSTRACT: Alzheimer's disease (AD) is one of the most serious public health concerns facing the world. Its characteristic feature is neuroinflammation due to microglial activation. Electroacupuncture is one of the therapies employed to improve the condition of patients with AD, although its mechanism of action is still to be determined. Triggering receptor expressed on myeloid cells 2 (TREM2) is a microglia-specific receptor that is involved in regulating neuroinflammation in AD. In this study, we applied senescence-accelerated mouse-prone 8 mice as the AD animal model, used the Morris water maze, and applied hematoxylin and eosin staining, immunofluorescence double staining, and Western blotting, to explore the effects and potential mechanisms of action of electroacupuncture. In summary, this study suggested that electroacupuncture treatment could improve the learning and memory abilities (p < 0.05) and protect neurons. These effects result from acupuncture could upregulate TREM2 expression in the hippocampus (p < 0.01), which was essential for the anti-inflammatory effects in the AD animal model. However, further studies are needed to conclusively demonstrate the mechanism of action of electroacupuncture in AD.

SUBMITTER: Li Y 

PROVIDER: S-EPMC7487106 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

Microglia TREM2: A Potential Role in the Mechanism of Action of Electroacupuncture in an Alzheimer's Disease Animal Model.

Li Yujie Y   Jiang Jing J   Tang Qisheng Q   Tian Huiling H   Wang Shun S   Wang Zidong Z   Liu Hao H   Yang Jiayi J   Ren Jingyu J  

Neural plasticity 20200904


Alzheimer's disease (AD) is one of the most serious public health concerns facing the world. Its characteristic feature is neuroinflammation due to microglial activation. Electroacupuncture is one of the therapies employed to improve the condition of patients with AD, although its mechanism of action is still to be determined. Triggering receptor expressed on myeloid cells 2 (TREM2) is a microglia-specific receptor that is involved in regulating neuroinflammation in AD. In this study, we applied  ...[more]

Similar Datasets

| S-EPMC6046445 | biostudies-literature
| S-EPMC7478730 | biostudies-literature
2015-03-13 | E-GEOD-65067 | biostudies-arrayexpress
| S-EPMC6909515 | biostudies-literature
| S-EPMC7520051 | biostudies-literature
| S-EPMC9783481 | biostudies-literature
| S-EPMC8564098 | biostudies-literature
| S-EPMC5767550 | biostudies-literature
| S-EPMC7826333 | biostudies-literature
| S-SCDT-10_1038-S44319-024-00077-X | biostudies-other